Company Registration No. 04827501 (England and Wales)
SEAGRAVE HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022
PAGES FOR FILING WITH REGISTRAR
SEAGRAVE HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
SEAGRAVE HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2022
31 March 2022
- 1 -
2022
2021
Notes
£
£
£
£
Fixed assets
Tangible assets
3
13,967
15,480
Investments
4
135,675
135,675
149,642
151,155
Current assets
Debtors
5
400,148
97,419
Cash at bank and in hand
791,418
814,710
1,191,566
912,129
Creditors: amounts falling due within one year
6
(222,255)
(186,585)
Net current assets
969,311
725,544
Net assets
1,118,953
876,699
Capital and reserves
Called up share capital
7
10,000
10,000
Profit and loss reserves
8
1,108,953
866,699
Total equity
1,118,953
876,699
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.
true
For the financial year ended 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
T
he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476
.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 11 May 2022 and are signed on its behalf by:
Professor O A D'Agnone
Director
Company Registration No. 04827501
SEAGRAVE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2022
- 2 -
1
Accounting policies
Company information
Seagrave Healthcare Limited is a
private
company
limited by shares
incorporated in
England and Wales
.
The registered office is
25A Eccleston Street, Belgravia, London, United Kingdom, SW1W 9NP.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in
sterling
, which is the functional currency of the company.
Monetary a
mounts
in these financial statements are
rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for
fees earned
provided in the normal course of business
.
1.3
Tangible fixed assets
Tangible fixed assets
are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures, fittings & equipment
20% on cost
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and
is credited or charged to profit or loss
.
1.4
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
The investments are assessed for impairment at each reporting date
and
any
impairment
losses or reversals of impairment losses are recognised immediately in
profit
or
loss
.
A subsidiary is an entity controlled by the company
. Control is
the power to govern the financial and operating policies of
the
entity so as to obtain benefits from its activities.
SEAGRAVE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
1
Accounting policies
(Continued)
- 3 -
1.5
Impairment of fixed assets
At each reporting
period
end date, the
company
reviews the carrying amounts of its tangible
assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the
company
estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.
1.6
Taxation
The tax expense represents the sum of the tax currently payable
only. No provision is made for deferred tax as any sum involved is not material.
1.7
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.8
Leases
Rentals payable under operating leases,
including
any lease incentives received, are charged to
profit or loss
on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease
s
asset are consumed.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was 7 (2021 - 9).
2022
2021
Number
Number
Total
7
9
SEAGRAVE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
- 4 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2021
57,329
Additions
6,488
At 31 March 2022
63,817
Depreciation and impairment
At 1 April 2021
41,849
Depreciation charged in the year
8,001
At 31 March 2022
49,850
Carrying amount
At 31 March 2022
13,967
At 31 March 2021
15,480
4
Fixed asset investments
2022
2021
£
£
Investment in subsidiary company
135,675
135,675
Movements in fixed asset investments
Shares in group undertakings
£
Cost or valuation
At 1 April 2021 & 31 March 2022
135,675
Carrying amount
At 31 March 2022
135,675
At 31 March 2021
135,675
SEAGRAVE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
- 5 -
5
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
30,603
860
Income tax on directors loan
22,611
22,611
Directors loan
332,354
70,868
Prepayments and accrued income
14,580
3,080
400,148
97,419
6
Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
23,330
5,634
Amounts due to group undertakings
93,715
106,300
Corporation tax
94,337
63,845
Other taxation and social security
5,736
5,564
Other creditors and accruals
5,137
5,242
222,255
186,585
7
Called up share capital
2022
2021
£
£
Ordinary share capital
Issued and fully paid
10,000 Ordinary shares of £1 each
10,000
10,000
8
Profit and loss reserves
2022
2021
£
£
At the beginning of the year
866,699
759,493
Profit for the year
402,254
267,206
Dividends
(160,000)
(160,000)
At the end of the year
1,108,953
866,699